Based on 784 businesses audited.
Medical Devices, Pharma & Biotech Reputation: VRAYLAR (AbbVie Inc.) (vraylar.com)
Vraylar.com is a high-substance, low-BS site that prioritizes regulatory transparency and clinical data over marketing air. The presence of ‘fluff’ is limited to emotional patient framing which is standard for consumer pharma, but the forensic medical data provides a massive concrete floor. This is a benchmark for how regulated industries should present substance.
Medical Devices, Pharma & Biotech Reputation: VRAYLAR (AbbVie Inc.) (vraylar.com)
The website perfectly aligns with the Pharma and Biotech industry classification. Its content is dominated by regulatory-required disclosure, clinical indications, and pharmacovigilance mechanisms.
“The score of 90 is driven by the heavy regulatory burden of the pharmaceutical industry, which forces a level of substance (ISI/Prescribing Info) that most industries avoid. Minor penalties were applied in Information Density for repetitive messaging and in Commodity Fingerprint for the use of standard pharma patient-story templates. Overall, the distance between the signal of 'relief' and the substance of 'clinical data' is minimal.”